Literature DB >> 15955052

Methods to monitor the quaternary structure of G protein-coupled receptors.

Graeme Milligan1, Michel Bouvier.   

Abstract

A wide range of approaches has been applied to examine the quaternary structure of G protein-coupled receptors, the basis of such protein-protein interactions and how such interactions might modulate the pharmacology and function of these receptors. These include co-immunoprecipitation, various adaptations of resonance energy transfer techniques, functional complementation studies and the analysis of ligand-binding data. Each of the available techniques has limitations that restrict interpretation of the data. However, taken together, they provide a coherent body of evidence indicating that many, if not all, G protein-coupled receptors exist and function as dimer/oligomers. Herein we assess the widely applied techniques and discuss the relative benefits and limitations of these approaches.

Mesh:

Substances:

Year:  2005        PMID: 15955052     DOI: 10.1111/j.1742-4658.2005.04731.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  67 in total

Review 1.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

2.  Third-party bioluminescence resonance energy transfer indicates constitutive association of membrane proteins: application to class a g-protein-coupled receptors and g-proteins.

Authors:  Sudhakiranmayi Kuravi; Tien-Hung Lan; Arnab Barik; Nevin A Lambert
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 3.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

4.  GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base.

Authors:  George Khelashvili; Kevin Dorff; Jufang Shan; Marta Camacho-Artacho; Lucy Skrabanek; Bas Vroling; Michel Bouvier; Lakshmi A Devi; Susan R George; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Richard R Neubig; Krzysztof Palczewski; Marc Parmentier; Jean-Philippe Pin; Gerrit Vriend; Fabien Campagne; Marta Filizola
Journal:  Bioinformatics       Date:  2010-05-25       Impact factor: 6.937

5.  Opioid and cannabinoid receptors: friends with benefits or just close friends?

Authors:  MacDonald J Christie
Journal:  Br J Pharmacol       Date:  2006-05-08       Impact factor: 8.739

Review 6.  A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization.

Authors:  G Milligan
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 7.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

8.  Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers.

Authors:  Peter J Harding; Helen Attrill; Jonas Boehringer; Simon Ross; George H Wadhams; Eleanor Smith; Judith P Armitage; Anthony Watts
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

Review 9.  G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function.

Authors:  Graeme Milligan
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

10.  Bioluminescence resonance energy transfer studies reveal constitutive dimerization of the human lutropin receptor and a lack of correlation between receptor activation and the propensity for dimerization.

Authors:  Rongbin Guan; Xiuyan Feng; Xueqing Wu; Meilin Zhang; Xuesen Zhang; Terence E Hébert; Deborah L Segaloff
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.